Back to News
Market Impact: 0.55

Volaris' SWOT analysis: airline stock navigates turbulence amid macro headwinds

VLRSBCSMS
Company FundamentalsAnalyst EstimatesAnalyst InsightsCorporate EarningsCorporate Guidance & OutlookEmerging MarketsTravel & LeisureTransportation & Logistics
Volaris' SWOT analysis: airline stock navigates turbulence amid macro headwinds

Volaris (VLRS), a low-cost Mexican airline, faces headwinds from macroeconomic uncertainty and a weak Mexico-US VFR market, leading Morgan Stanley to cut its 2025 EBITDAR forecast by 19% to $957M and 2026 by 16% to $1.184B. While maintaining profitability with recent EPS of $0.04, net income is expected to drop this year, and 2025 EPS is projected at -$1.19 before recovering to $0.07 in 2026; however, analysts maintain cautious optimism for long-term recovery driven by capacity discipline and low-cost model, with Barclays maintaining an overweight rating with a $4.50 target.

Analysis

Volaris (VLRS) is navigating a challenging period marked by macroeconomic uncertainties and shifting market dynamics, particularly impacting its crucial Mexico-U.S. Visiting Friends and Relatives (VFR) market due to prolonged U.S. immigration policy ambiguity. The company reported softer-than-anticipated Q1 2025 results, and while maintaining a trailing twelve-month EPS of $0.04, net income is projected to decline in the current year. Morgan Stanley significantly reduced its 2025 EBITDAR forecast for Volaris by 19% to $957 million and its 2026 forecast by 16% to $1,184 million, reflecting these headwinds. EPS projections underscore near-term difficulties, with an estimated -$1.19 for 2025, before an anticipated recovery to $0.07 in 2026 and further growth to $0.76 by 2028. Despite these challenges and a 43.8% stock price decline over the past six months to $4.40 as of April 2025, Volaris's commitment to capacity discipline is viewed positively by analysts, potentially aiding yield management. InvestingPro suggests the stock is undervalued at current levels, trading at a P/E ratio of 12.06, although it was not highlighted as a top AI-selected pick. Analyst sentiment is mixed, with Morgan Stanley issuing an Equal-weight rating ($4.40 PT) and Barclays an Overweight rating ($4.50 PT as of April 29, 2025, a significant reduction from its $12.00 PT in February 2025), indicating a cautious outlook despite long-term recovery potential driven by its low-cost model and expected sequential yield recovery in H2 2025, contingent on macroeconomic stabilization.